Want to see IN:TIRUMALCHM full AI Analyst Report?
Thirumalai Chemicals Limited (TIRUMALCHM) AI Stock Analysis
Thirumalai Chemicals Limited
(NSE:TIRUMALCHM)
The score is dragged down primarily by deteriorating fundamentals—multi-year losses, declining revenue, higher leverage, and negative operating/free cash flow—followed by clearly bearish technical momentum (price below key moving averages with negative MACD). Valuation contributes only modestly because the negative P/E reflects loss-making conditions and dividend yield data is unavailable.
Thirumalai Chemicals Limited (TIRUMALCHM) vs. iShares MSCI India ETF (INDA)
- Market Cap
- INR 13.78B
- Dividend Yield
- ―
- Average Volume (3M)
- 32.33K
- Price to Earnings (P/E)
- -8.8
- Beta (1Y)
- 1.27
- Revenue Growth
- -5.80%
- EPS Growth
- -19.15%
- Country
- India
- Employees
- 537
- Sector
- General
- Sector Strength
- 55
- Industry
- Chemicals - Specialty
Thirumalai Chemicals Limited Business Overview & Revenue Model
Company Description
Thirumalai Chemicals Limited, founded in 1972 and based in Mumbai, India, specializes in the manufacturing and sale of organic chemicals domestically. The company's product offerings include key compounds such as phthalic anhydride, maleic anhydride,...
How the Company Makes Money
The company makes money primarily by manufacturing chemicals and selling them to industrial customers. Its core revenue stream is product sales from its chemical portfolio (including phthalic anhydride and downstream derivatives), earned through cont...
Thirumalai Chemicals Limited Financial Statement Overview
Summary
Financial performance is very weak: profitability has swung from solid FY2021–FY2022 levels to sustained losses in FY2024–FY2026, with FY2026 showing negative EBIT margin (~-7.1%) and net margin (~-9.7%) alongside three straight years of revenue decline. Leverage is elevated (debt-to-equity ~1.39 in FY2026), reducing flexibility during losses. Cash flow quality is poor, with negative operating cash flow in FY2025–FY2026 and mostly negative free cash flow (especially large outflow in FY2026).
Income Statement
28NegativeBalance Sheet
35NegativeCash Flow
22Negative| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 18.32B | 17.36B | 20.50B | 20.72B | 21.20B | 19.97B |
| Gross Profit | 2.51B | 1.92B | 4.63B | 3.87B | 6.01B | 7.65B |
| EBITDA | 287.10M | -244.30M | 488.00M | 645.40M | 2.16B | 4.52B |
| Net Income | -1.52B | -1.68B | -461.00M | -387.90M | 898.30M | 2.81B |
Balance Sheet | ||||||
| Total Assets | 0 | 47.37B | 38.07B | 33.20B | 23.60B | 18.62B |
| Cash, Cash Equivalents and Short-Term Investments | 678.50M | 2.62B | 1.86B | 4.49B | 4.59B | 5.54B |
| Total Debt | 0 | 21.75B | 17.86B | 12.52B | 5.14B | 1.65B |
| Total Liabilities | -15.64B | 31.73B | 26.51B | 21.74B | 11.68B | 7.77B |
| Stockholders Equity | 15.64B | 15.64B | 11.56B | 11.46B | 11.92B | 10.85B |
Cash Flow | ||||||
| Free Cash Flow | -6.28B | -8.98B | -6.79B | -5.74B | -3.09B | 3.29B |
| Operating Cash Flow | -2.68B | -2.99B | -658.80M | 2.37B | 541.30M | 4.02B |
| Investing Cash Flow | -3.50B | -6.04B | -5.42B | -8.31B | -3.59B | -1.39B |
| Financing Cash Flow | 6.18B | 7.75B | 3.75B | 6.43B | 2.06B | -699.80M |
Thirumalai Chemicals Limited Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:TIRUMALCHM, the sentiment is Negative. The current price of 113.95 is below the 20-day moving average (MA) of 133.72, below the 50-day MA of 147.86, and below the 200-day MA of 176.46, indicating a bearish trend. The MACD of -9.93 indicates Positive momentum. The RSI at 21.92 is Positive, neither overbought nor oversold. The STOCH value of 9.56 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for IN:TIRUMALCHM.
Thirumalai Chemicals Limited Peers Comparison
Overall Rating
IN:VINATIORGA56Neutral
IN:TATVA55Neutral
IN:ANURAS49Neutral
IN:AARTIIND47Neutral
IN:JUBLINGREA46Neutral- IN:TIRUMALCHM43Neutral
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| IN:VINATIORGA | 56Neutral | INR 102.97B | 22.93 | ― | 0.86% | 10.98% | -5.48% |
| Sector * | 55Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% |
| IN:TATVA | 55Neutral | INR 38.49B | 61.11 | ― | 0.12% | 49.69% | 254.75% |
| IN:ANURAS | 49Neutral | INR 129.99B | 74.35 | ― | 0.13% | 51.77% | 36.90% |
| IN:AARTIIND | 47Neutral | INR 157.96B | 29.74 | ― | 0.23% | 39.85% | 103.71% |
| IN:JUBLINGREA | 46Neutral | INR 89.05B | 25.14 | ― | 0.89% | 15.41% | 21.76% |
| IN:TIRUMALCHM | 43Neutral | INR 13.74B | -8.84 | ― | ― | -5.80% | -19.15% |
* General Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| IN:TIRUMALCHM | Thirumalai Chemicals Limited | 113.95 | -169.90 | -59.86% | |
| IN:AARTIIND | AARTI Industries Ltd | 435.45 | 47.72 | 12.31% | |
| IN:ANURAS | Anupam Rasayan India Ltd. | 1141.80 | 61.23 | 5.67% | |
| IN:JUBLINGREA | Jubilant Ingrevia Ltd. | 559.05 | -127.98 | -18.63% | |
| IN:TATVA | Tatva Chintan Pharma Chem Limited | 1645.45 | 235.40 | 16.69% | |
| IN:VINATIORGA | Vinati Organics Limited | 993.30 | -663.32 | -40.04% |
Thirumalai Chemicals Limited Corporate Events
Thirumalai Chemicals Promoter Group Members Seek Reclassification as Public Shareholders
Thirumalai Chemicals Limited has received formal requests from two members of its promoter group to reclassify their shareholding status to public under SEBI’s Listing Obligations and Disclosure Requirements. The applicants, Narayan Santhanam a...
Thirumalai Chemicals Faces Customs Audit Over Export Incentive Benefits
Thirumalai Chemicals Limited has disclosed that it received an audit communication from the Office of the Commissioner of Customs Audit in Chennai regarding shipping bills filed for its exports under the DFIA scheme. The customs authority alleges ine...
Thirumalai Chemicals Files SEBI-Mandated Dematerialisation Compliance Certificate
Thirumalai Chemicals Limited has submitted a confirmation certificate to the National Stock Exchange of India and BSE for the quarter ended September 30, 2026, in compliance with Regulation 74(5) of the SEBI (Depositories and Participants) Regulation...
Thirumalai Chemicals to Monetise Part Stake in Ultramarine & Pigments
Thirumalai Chemicals Limited has approved a plan to sell up to 950,000 equity shares in Ultramarine & Pigments Limited, a company in which it is a promoter shareholder. The stake sale, representing about 3.25% of Ultramarine & Pigments’...
Thirumalai Chemicals to Sell Part of Promoter Stake in Ultramarine & Pigments
Thirumalai Chemicals has announced that its Fund Raising Committee approved the sale of up to 1,460,000 equity shares in Ultramarine & Pigments Limited, a company in which Thirumalai currently holds a 14.38% stake as promoter. The proposed sale,...
Thirumalai Chemicals Plays Down Impact of GST Show Cause Notice
Thirumalai Chemicals Limited has disclosed that it received a show cause notice from the Assistant Commissioner, Central GST and Central Excise, Audit Commissionerate, Vadodara, following an audit conducted under Section 65 of the CGST Act, 2017. The...
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Aug 21, 2026